Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Colonic Neoplasms 11Rectal Neoplasms 10Stomach Neoplasms 8Cholangiocarcinoma 8Neoplasm Metastasis 7Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Neoplasms 2Liver Neoplasms 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma Of Esophagus 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Genetic Diseases, Inborn 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Colorectal Adenocarcinoma Metastatic to the Liver 1Carcinoma, Pancreatic Ductal 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1

Interventions

Paclitaxel 134Carboplatin 129Bevacizumab 86Gemcitabine 45pembrolizumab 37olaparib 33Cisplatin 30liposomal doxorubicin 29Docetaxel 29Cyclophosphamide 29Topotecan 28niraparib 27Taxes 20Etoposide 18Filgrastim 16Doxorubicin 16Immunoglobulin G 15Disulfides 15apatinib 12Letrozole 12Albumin-Bound Paclitaxel 12Drug Therapy 11fluzoparib 10fludarabine 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Biopsy 10durvalumab 9Nivolumab 9pazopanib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Neoplasms × Floxuridine × Clear all
NCT00005049 2011-04-06

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

NYU Langone Health

Phase 2 Completed
45 enrolled
GastrointestinalGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Colonic Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡